Header Logo

Connection

Constance Weisner to Substance-Related Disorders

This is a "connection" page, showing publications Constance Weisner has written about Substance-Related Disorders.
Connection Strength

18.679
  1. Specialty addiction and psychiatry treatment initiation and engagement: Results from an SBIRT randomized trial in pediatrics. J Subst Abuse Treat. 2017 11; 82:48-54.
    View in: PubMed
    Score: 0.420
  2. Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy. Subst Use Misuse. 2017 08 24; 52(10):1283-1291.
    View in: PubMed
    Score: 0.407
  3. Trajectories of remission and mortality over 13 years after intake to substance use treatment. Am J Drug Alcohol Abuse. 2017 09; 43(5):583-590.
    View in: PubMed
    Score: 0.404
  4. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial. JAMA Psychiatry. 2016 Aug 01; 73(8):804-14.
    View in: PubMed
    Score: 0.389
  5. A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression. J Consult Clin Psychol. 2016 Jul; 84(7):571-9.
    View in: PubMed
    Score: 0.379
  6. Implementation of Screening, Brief Intervention, and Referral to Treatment for Adolescents in Pediatric Primary Care: A Cluster Randomized Trial. JAMA Pediatr. 2015 Nov; 169(11):e153145.
    View in: PubMed
    Score: 0.370
  7. Advising depression patients to reduce alcohol and drug use: factors associated with provider intervention in outpatient psychiatry. Am J Addict. 2014 Nov-Dec; 23(6):570-5.
    View in: PubMed
    Score: 0.340
  8. Effectiveness of nurse-practitioner-delivered brief motivational intervention for young adult alcohol and drug use in primary care in South Africa: a randomized clinical trial. Alcohol Alcohol. 2014 Jul-Aug; 49(4):430-8.
    View in: PubMed
    Score: 0.335
  9. Comparison of health care needs of child family members of adults with alcohol or drug dependence versus adults with asthma or diabetes. J Dev Behav Pediatr. 2014 May; 35(4):282-91.
    View in: PubMed
    Score: 0.333
  10. Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV. Psychiatr Serv. 2013 Aug 01; 64(8):745-53.
    View in: PubMed
    Score: 0.316
  11. 12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity. Subst Abus. 2013; 34(1):33-42.
    View in: PubMed
    Score: 0.304
  12. Integrating substance use treatment into adolescent health care. Curr Psychiatry Rep. 2012 Oct; 14(5):453-61.
    View in: PubMed
    Score: 0.298
  13. Motivational interviewing to reduce hazardous drinking and drug use among depression patients. J Subst Abuse Treat. 2013 Mar; 44(3):323-9.
    View in: PubMed
    Score: 0.298
  14. Performance measures for substance use disorders--what research is needed? Addict Sci Clin Pract. 2012 Sep 11; 7:18.
    View in: PubMed
    Score: 0.297
  15. Screening for adolescent alcohol and drug use in pediatric health-care settings: predictors and implications for practice and policy. Addict Sci Clin Pract. 2012 Aug 16; 7:13.
    View in: PubMed
    Score: 0.296
  16. Effects of age and life transitions on alcohol and drug treatment outcome over nine years. J Stud Alcohol Drugs. 2012 May; 73(3):459-68.
    View in: PubMed
    Score: 0.290
  17. Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan. Addiction. 2012 May; 107(5):933-42.
    View in: PubMed
    Score: 0.285
  18. Remission from alcohol and other drug problem use in public and private treatment samples over seven years. Drug Alcohol Depend. 2012 Jul 01; 124(1-2):57-62.
    View in: PubMed
    Score: 0.283
  19. Innovative policy strategies need empirical evaluation. Addiction. 2011 Dec; 106(12):2069-70.
    View in: PubMed
    Score: 0.282
  20. Continuing care and long-term substance use outcomes in managed care: early evidence for a primary care-based model. Psychiatr Serv. 2011 Oct; 62(10):1194-200.
    View in: PubMed
    Score: 0.278
  21. Patterns of alcohol and drug use among depressed older adults seeking outpatient psychiatric services. Am J Geriatr Psychiatry. 2011 Aug; 19(8):695-703.
    View in: PubMed
    Score: 0.275
  22. Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. Drug Alcohol Depend. 2011 Apr 01; 114(2-3):110-8.
    View in: PubMed
    Score: 0.261
  23. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS. 2010 Nov; 24(11):705-12.
    View in: PubMed
    Score: 0.261
  24. Individuals receiving addiction treatment: are medical costs of their family members reduced? Addiction. 2010 Jul; 105(7):1226-34.
    View in: PubMed
    Score: 0.253
  25. Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med. 2010; 40(1):57-76.
    View in: PubMed
    Score: 0.247
  26. Substance use, symptom, and employment outcomes of persons with a workplace mandate for chemical dependency treatment. Psychiatr Serv. 2009 May; 60(5):646-54.
    View in: PubMed
    Score: 0.235
  27. Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care. Alcohol Clin Exp Res. 2009 Aug; 33(8):1417-29.
    View in: PubMed
    Score: 0.235
  28. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction. 2009 Jun; 104(6):927-39.
    View in: PubMed
    Score: 0.233
  29. Stress, substance use and sexual risk behaviors among primary care patients in Cape Town, South Africa. AIDS Behav. 2010 Apr; 14(2):359-70.
    View in: PubMed
    Score: 0.232
  30. Family members of people with alcohol or drug dependence: health problems and medical cost compared to family members of people with diabetes and asthma. Addiction. 2009 Feb; 104(2):203-14.
    View in: PubMed
    Score: 0.231
  31. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9.
    View in: PubMed
    Score: 0.227
  32. The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients. Drug Alcohol Depend. 2008 Nov 01; 98(1-2):45-53.
    View in: PubMed
    Score: 0.222
  33. Nine-year psychiatric trajectories and substance use outcomes: an application of the group-based modeling approach. Eval Rev. 2008 Feb; 32(1):39-58.
    View in: PubMed
    Score: 0.216
  34. Prevalence and correlates of substance use among South African primary care clinic patients. Subst Use Misuse. 2008; 43(10):1395-410.
    View in: PubMed
    Score: 0.215
  35. Substance use, education, employment, and criminal activity outcomes of adolescents in outpatient chemical dependency programs. J Behav Health Serv Res. 2009 Jan; 36(1):75-95.
    View in: PubMed
    Score: 0.214
  36. Gender differences in seven-year alcohol and drug treatment outcomes among older adults. Am J Addict. 2007 May-Jun; 16(3):216-21.
    View in: PubMed
    Score: 0.205
  37. Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend. 2007 Sep 06; 90(1):72-80.
    View in: PubMed
    Score: 0.204
  38. The excess medical cost and health problems of family members of persons diagnosed with alcohol or drug problems. Med Care. 2007 Feb; 45(2):116-22.
    View in: PubMed
    Score: 0.201
  39. Medical conditions of adolescents in alcohol and drug treatment: comparison with matched controls. J Adolesc Health. 2007 Feb; 40(2):173-9.
    View in: PubMed
    Score: 0.199
  40. Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes. Alcohol Clin Exp Res. 2006 May; 30(5):851-9.
    View in: PubMed
    Score: 0.191
  41. Addiction treatment history, medical services utilization, and cost: a longitudinal analysis of problem drinkers. J Addict Dis. 2006; 25(1):105-20.
    View in: PubMed
    Score: 0.187
  42. Adolescents with co-occurring substance use and mental conditions in a private managed care health plan: prevalence, patient characteristics, and treatment initiation and engagement. Am J Addict. 2006; 15 Suppl 1:67-79.
    View in: PubMed
    Score: 0.187
  43. Health care services use by adolescents with intakes into an outpatient alcohol and drug treatment program. Am J Addict. 2006; 15 Suppl 1:113-21.
    View in: PubMed
    Score: 0.187
  44. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample. Drug Alcohol Depend. 2005 Nov 01; 80(2):231-40.
    View in: PubMed
    Score: 0.185
  45. Adolescents in private chemical dependency programs: who are most at risk for HIV? J Subst Abuse Treat. 2005 Jul; 29(1):39-45.
    View in: PubMed
    Score: 0.180
  46. Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes. Alcohol Clin Exp Res. 2005 May; 29(5):801-9.
    View in: PubMed
    Score: 0.178
  47. Substance misuse: what place for women-only treatment programs? Addiction. 2005 Jan; 100(1):7-8.
    View in: PubMed
    Score: 0.174
  48. Pathways to chemical dependency treatment for adolescents in an HMO. J Psychoactive Drugs. 2004 Dec; 36(4):439-53.
    View in: PubMed
    Score: 0.173
  49. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry. 2004 Nov 15; 56(10):703-13.
    View in: PubMed
    Score: 0.173
  50. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction. 2004 Oct; 99(10):1286-97.
    View in: PubMed
    Score: 0.171
  51. Family environment factors and substance abuse severity in an HMO adolescent treatment population. Clin Pediatr (Phila). 2004 May; 43(4):323-33.
    View in: PubMed
    Score: 0.166
  52. Adolescents with substance diagnoses in an HMO: factors associated with medical provider referrals to substance abuse and mental health treatment. Ment Health Serv Res. 2004 Mar; 6(1):47-60.
    View in: PubMed
    Score: 0.165
  53. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med. 2003 Nov 10; 163(20):2511-7.
    View in: PubMed
    Score: 0.161
  54. Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program. J Stud Alcohol. 2003 Jul; 64(4):520-30.
    View in: PubMed
    Score: 0.157
  55. Utilization and cost impact of integrating substance abuse treatment and primary care. Med Care. 2003 Mar; 41(3):357-67.
    View in: PubMed
    Score: 0.154
  56. Changes in smoking status among substance abusers: baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up. Drug Alcohol Depend. 2003 Jan 24; 69(1):61-71.
    View in: PubMed
    Score: 0.152
  57. Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. J Stud Alcohol. 2002 Nov; 63(6):673-82.
    View in: PubMed
    Score: 0.150
  58. Patterns of Health Care Use 5 Years After an Intervention Linking Patients in Addiction Treatment With a Primary Care Practitioner. JAMA Netw Open. 2022 11 01; 5(11):e2241338.
    View in: PubMed
    Score: 0.150
  59. Young Adult Substance Use and Healthcare Use Associated With Screening, Brief Intervention and Referral to Treatment in Pediatric Primary Care. J Adolesc Health. 2022 10; 71(4S):S15-S23.
    View in: PubMed
    Score: 0.149
  60. Coping among individuals seeking private chemical dependence treatment: gender differences and impact on length of stay in treatment. Alcohol Clin Exp Res. 2002 Aug; 26(8):1228-33.
    View in: PubMed
    Score: 0.147
  61. A prospective study of the factors influencing entry to alcohol and drug treatment. J Behav Health Serv Res. 2002 May; 29(2):126-37.
    View in: PubMed
    Score: 0.145
  62. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001 Oct 10; 286(14):1715-23.
    View in: PubMed
    Score: 0.139
  63. Factors affecting the initiation of substance abuse treatment in managed care. Addiction. 2001 May; 96(5):705-16.
    View in: PubMed
    Score: 0.135
  64. Access to alcohol treatment in the 21st century. Old worries and new optimism. Overview. Recent Dev Alcohol. 2001; 15:99-105.
    View in: PubMed
    Score: 0.132
  65. Three-Year Outcomes After Brief Treatment of Substance Use and Mood Symptoms. Pediatrics. 2021 01; 147(1).
    View in: PubMed
    Score: 0.132
  66. Predictors of substance abuse treatment retention among women and men in an HMO. Alcohol Clin Exp Res. 2000 Oct; 24(10):1525-33.
    View in: PubMed
    Score: 0.130
  67. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens. Health Serv Res. 2000 Oct; 35(4):791-812.
    View in: PubMed
    Score: 0.130
  68. Addiction severity index data from general membership and treatment samples of HMO members. One case of norming the ASI. J Subst Abuse Treat. 2000 Sep; 19(2):103-9.
    View in: PubMed
    Score: 0.129
  69. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system. J Subst Abuse Treat. 2020 11; 118:108097.
    View in: PubMed
    Score: 0.128
  70. Trends and correlates of self-reported alcohol and nicotine use among women before and during pregnancy, 2009-2017. Drug Alcohol Depend. 2020 09 01; 214:108168.
    View in: PubMed
    Score: 0.128
  71. Correlates of Pregnant Women's Participation in a Substance Use Assessment and Counseling Intervention Integrated into Prenatal Care. Matern Child Health J. 2020 Apr; 24(4):423-431.
    View in: PubMed
    Score: 0.125
  72. Drinking patterns and problems of the "stably insured": a study of the membership of a health maintenance organization. J Stud Alcohol. 2000 Jan; 61(1):121-9.
    View in: PubMed
    Score: 0.123
  73. New directions in alcohol and drug treatment under managed care. Am J Manag Care. 1999 Jun 25; 5 Spec No:SP57-69.
    View in: PubMed
    Score: 0.119
  74. Patterns of marijuana use among psychiatry patients with depression and its impact on recovery. J Affect Disord. 2017 Apr 15; 213:168-171.
    View in: PubMed
    Score: 0.101
  75. Gender differences in the relationship of alcohol and drug use to criminal behavior in a sample of arrestees. Am J Drug Alcohol Abuse. 1997 Feb; 23(1):129-41.
    View in: PubMed
    Score: 0.101
  76. Specifying and Pilot Testing Quality Measures for the American Society of Addiction Medicine's Standards of Care. J Addict Med. 2016 May-Jun; 10(3):148-55.
    View in: PubMed
    Score: 0.096
  77. Point Prevalence of Co-Occurring Behavioral Health Conditions and Associated Chronic Disease Burden Among Adolescents. J Am Acad Child Adolesc Psychiatry. 2016 05; 55(5):408-14.
    View in: PubMed
    Score: 0.095
  78. Expanding the frame of health services research in the drug abuse field. Health Serv Res. 1995 Dec; 30(5):707-26.
    View in: PubMed
    Score: 0.093
  79. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Drug Alcohol Depend. 2016 Jan 01; 158:1-7.
    View in: PubMed
    Score: 0.093
  80. Screening and brief intervention for substance misuse: Does it reduce aggression and HIV-related risk behaviours? Alcohol Alcohol. 2015 May; 50(3):302-9.
    View in: PubMed
    Score: 0.088
  81. The association between DSM-III-R alcohol dependence, psychological distress and drug use. Addiction. 1995 Mar; 90(3):351-9.
    View in: PubMed
    Score: 0.088
  82. Drinking problems and self-reported criminal behavior, arrests and convictions: 1990 US alcohol and 1989 county surveys. Addiction. 1995 Mar; 90(3):361-73.
    View in: PubMed
    Score: 0.088
  83. Assessing bias in community-based prevalence estimates: towards an unduplicated count of problem drinkers and drug users. Addiction. 1995 Mar; 90(3):391-405.
    View in: PubMed
    Score: 0.088
  84. Significant life events and their impact on alcohol and drug use: a qualitative study. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):450-9.
    View in: PubMed
    Score: 0.086
  85. Does age at first treatment episode make a difference in outcomes over 11 years? J Subst Abuse Treat. 2014 Apr; 46(4):482-90.
    View in: PubMed
    Score: 0.081
  86. Alcohol and drug treatment involvement, 12-step attendance and abstinence: 9-year cross-lagged analysis of adults in an integrated health plan. J Subst Abuse Treat. 2014 Apr; 46(4):412-9.
    View in: PubMed
    Score: 0.081
  87. Alcohol and drug problems among diverse health and social service populations. Am J Public Health. 1993 Jun; 83(6):824-9.
    View in: PubMed
    Score: 0.078
  88. The epidemiology of combined alcohol and drug use within treatment agencies: a comparison by gender. J Stud Alcohol. 1993 May; 54(3):268-74.
    View in: PubMed
    Score: 0.078
  89. The role of continuing care in 9-year cost trajectories of patients with intakes into an outpatient alcohol and drug treatment program. Med Care. 2012 Jun; 50(6):540-6.
    View in: PubMed
    Score: 0.073
  90. Peer influences on adolescent alcohol and other drug use outcomes. J Nurs Scholarsh. 2012 Mar; 44(1):36-44.
    View in: PubMed
    Score: 0.071
  91. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012 Mar; 13(3):266-75.
    View in: PubMed
    Score: 0.071
  92. A comparison of alcohol and drug treatment clients: are they from the same population? Am J Drug Alcohol Abuse. 1992; 18(4):429-44.
    View in: PubMed
    Score: 0.071
  93. The merging of alcohol and drug treatment: a policy review. J Public Health Policy. 1992; 13(1):66-80.
    View in: PubMed
    Score: 0.071
  94. Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program. Alcohol Clin Exp Res. 2011 Feb; 35(2):203-10.
    View in: PubMed
    Score: 0.065
  95. Access to treatment for adolescents with substance use and co-occurring disorders: challenges and opportunities. J Am Acad Child Adolesc Psychiatry. 2010 Jul; 49(7):637-46; quiz 725-6.
    View in: PubMed
    Score: 0.063
  96. Predictors of longitudinal substance use and mental health outcomes for patients in two integrated service delivery systems. Drug Alcohol Depend. 2010 Jul 01; 110(1-2):92-100.
    View in: PubMed
    Score: 0.063
  97. Day hospital and residential addiction treatment: randomized and nonrandomized managed care clients. J Consult Clin Psychol. 2007 Dec; 75(6):947-59.
    View in: PubMed
    Score: 0.053
  98. Cigarette smoking and long-term alcohol and drug treatment outcomes: a telephone follow-up at five years. Am J Addict. 2007 Jan-Feb; 16(1):32-7.
    View in: PubMed
    Score: 0.050
  99. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50.
    View in: PubMed
    Score: 0.048
  100. Readmission among chemical dependency patients in private, outpatient treatment: patterns, correlates and role in long-term outcome. J Stud Alcohol. 2005 Nov; 66(6):842-7.
    View in: PubMed
    Score: 0.046
  101. Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. Alcohol Clin Exp Res. 2005 Jun; 29(6):989-98.
    View in: PubMed
    Score: 0.045
  102. Relationship between use of psychiatric services and five-year alcohol and drug treatment outcomes. Psychiatr Serv. 2005 Feb; 56(2):164-71.
    View in: PubMed
    Score: 0.044
  103. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug Alcohol Depend. 2003 Sep 10; 71(3):281-94.
    View in: PubMed
    Score: 0.040
  104. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis. J Stud Alcohol. 2001 Jan; 62(1):89-97.
    View in: PubMed
    Score: 0.033
  105. Demographic characteristics, life context, and patterns of substance use among alcohol-dependent treatment clients in a health maintenance organization. Alcohol Clin Exp Res. 2000 Dec; 24(12):1803-10.
    View in: PubMed
    Score: 0.033
  106. Smoking and cessation treatment among persons with and without HIV in a U.S. integrated health system. Drug Alcohol Depend. 2020 08 01; 213:108128.
    View in: PubMed
    Score: 0.032
  107. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am J Psychiatry. 2000 Apr; 157(4):588-94.
    View in: PubMed
    Score: 0.031
  108. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose. Drug Alcohol Depend. 2020 04 01; 209:107923.
    View in: PubMed
    Score: 0.031
  109. Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial. Contemp Clin Trials. 2019 09; 84:105833.
    View in: PubMed
    Score: 0.030
  110. Substance abuse and the course of welfare dependency. Am J Public Health. 1998 Nov; 88(11):1616-22.
    View in: PubMed
    Score: 0.028
  111. The relationship of pre-treatment Alcoholics Anonymous affiliation with problem severity, social resources and treatment history. Drug Alcohol Depend. 1998 Jan 01; 49(2):123-31.
    View in: PubMed
    Score: 0.027
  112. Alcohol screening and changes in problem drinking behaviors in medical care settings: a longitudinal perspective. J Stud Alcohol Drugs. 2011 May; 72(3):471-9.
    View in: PubMed
    Score: 0.017

© 2024 Kaiser Permanente